Can drugs be designed?
- 31 December 1997
- journal article
- review article
- Published by Elsevier in Current Opinion in Biotechnology
- Vol. 8 (6) , 696-700
- https://doi.org/10.1016/s0958-1669(97)80122-x
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Designing Combinatorial Library Mixtures Using a Genetic AlgorithmJournal of Medicinal Chemistry, 1997
- Stromelysin Inhibitors Designed from Weakly Bound Fragments: Effects of Linking and CooperativityJournal of the American Chemical Society, 1997
- Serendipity meets precision: the integration of structure-based drug design and combinatorial chemistry for efficient drug discoveryStructure, 1997
- Structure-Based Design of a Potent, Selective, and Irreversible Inhibitor of the Catalytic Domain of the erbB Receptor Subfamily of Protein Tyrosine KinasesJournal of Medicinal Chemistry, 1997
- Structure-Based Design of Substituted Diphenyl Sulfones and Sulfoxides as Lipophilic Inhibitors of Thymidylate SynthaseJournal of Medicinal Chemistry, 1997
- Design and synthesis of carbohydrate-based inhibitors of protein—carbohydrate interactionsCurrent Opinion in Structural Biology, 1996
- Molecular basis for the binding of SH3 ligands with non-peptide elements identified by combinatorial synthesisChemistry & Biology, 1996
- Modeling protein—ligand complexesCurrent Opinion in Structural Biology, 1996
- Structure-Based Design of HIV Protease Inhibitors: 5,6-Dihydro-4-hydroxy-2-pyrones as Effective, Nonpeptidic InhibitorsJournal of Medicinal Chemistry, 1996
- Bis Tertiary Amide Inhibitors of the HIV-1 Protease Generated via Protein Structure-Based Iterative DesignJournal of Medicinal Chemistry, 1996